Getting a grip can be difficult for patients with rheumatoid arthritis or psoriatic arthritis. Yet, when we examined biologic administration devices, it seemed that an ordinary bike handle had a leg up in terms of ergonomic design. How are patients supposed to administer their medicine when they struggle to grasp their injection device? A design team looked into the ergonomics.
Syringes have continued to evolve over the centuries. Once an experimental surgical procedure, injections are now routinely performed at home by patients. So, we asked ourselves how today’s technology might help change the patient injection process.
A button is just something you press to get a task done. Or is it? Buttons do just about everything, which is why they come in an almost endless variety of shapes and sizes, each tailor-made for the task at hand. We wanted to take a closer look at what makes a button work best so we could design one that acknowledges the very specific needs of patients with rheumatoid arthritis or psoriatic arthritis.
Do you ever wonder how patients are really doing outside of office visits? Some patients document their experiences by tracking their health in a journal or a mobile app. But often, the information isn’t conveyed well or even at all during an office visit. We wanted to find a convenient way for patients to consistently collect information about key signs and symptoms and easily share it with their physicians.
Watching an airplane take flight looks easy and smooth. It's actually a meticulous science based on accurate and consistent measurements. Combustors precisely regulate the fuel injection rate to help maintain a controlled and consistent propulsion during flight. Similarly, the self-injection process aims to bring a consistent and controlled experience. Our device engineers explored the operational components.
Sometimes, revisiting the science and challenging old assumptions can bring new understanding to what was once ambiguous. For patients with psoriatic arthritis, we thought there were still many open questions. We wanted to reevaluate how best to treat psoriatic arthritis, so we set out to develop a new clinical trial.